Building the future of drug discovery
We're a team of scientists, ML researchers, engineers, and dreamers working to transform how medicines are discovered and developed.
Simulate life so we can build drugs faster
Led by Michael Antonov, a co-founder of Oculus, and well-funded by Formic Ventures, Deep Origin is poised to reinvent the way scientists work and life science innovations come to life.
We see a future largely free of diseases, with a 150-year lifespan being a norm. To get there, we are building an operating system for science, enabling scientists to be more productive and to bring tomorrow's ideas to life quickly and at a reasonable cost.
Executive Team
Michael Antonov
Co-Founder and CEO
Garegin Papoian, Ph.D.
Co-Founder and CSO
Matt Shlosberg
COO
Ashot Papoyan, Ph.D.
COO-Scientific Development
Henk Campher
Head of Revenue / CMO
Natalie Ma, Ph.D.
Chief Business Officer
Team Leads
The experts driving innovation across our platform.
Tigran Abramyan, Ph.D.
Principal Scientist, Computational Drug Design
Grigor Arakelov, Ph.D.
In Silico Drug Discovery Team Lead
Elin Barnes
Program Management
Merrill Cook
Marketing Director
Aram Davtyan, Ph.D.
AWSEM Team Lead
Gor Lavchyan
Head of Global Operations
Garik Petrosyan, Ph.D.
Head of AI
Oliver Purcell, Ph.D.
Cell-Sim Principal Scientist
Max Ratnikov, Ph.D.
Product Manager - Cheminformatics
Hayk Saribekyan, Ph.D.
Head of R&D (Molecular Dynamics)
Khachik Smbatyan
Balto Team Lead
Vito Spadavecchio
Product
Join Our Team
Help us build the future of drug discovery. We're looking for passionate people who want to make a difference.